Bank of America Corporation »

An2 Therapeutics shares owned by Bank of America Corporation

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Bank of America Corporation from 13F filings

Historical chart of Bank of America Corporation investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Bank of America Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $49k 15k 3.25
2023-12-31 $449k 22k 20.49
2023-09-30 $50k 3.1k 16.08
2023-06-30 $104k 12k 8.50
2023-03-31 $256k 26k 9.87
2022-12-31 $236k 25k 9.53
2022-06-30 $13k 1.6k 7.93